Stock Events

Stock Events

Nektar Therapeutics (ITH.F) Q2 2024 Earnings

9MayConfirmed

Q2 2023

Q3 2023

Q4 2023

Q2 2024

-0.2

-0.19

-0.19

-0.18

Details

Expected EPS

-0.17616800000000002

Actual EPS

-0.17616800000000002

Surprise EPS

0

Surprise Percent

+0%

Description

Nektar Therapeutics (ITH.F) has reported earnings of -0.17616800000000002 per share for Q2 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.